NCT01603940View on ClinicalTrials.gov

Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
HypertensionDiabetes Mellitus
Interventions
DRUG

Benazepril

Patients in this group will receive 20 mg of benazepril per day, orally, during 12 weeks.

DRUG

Losartan

Patients in this group will receive 100 mg of losartan per day, orally, during 12 weeks.

Trial Locations (1)

20551030

Hospital Universitario Pedro Ernesto, Rio de Janeiro

All Listed Sponsors
lead

Hospital Universitario Pedro Ernesto

OTHER

NCT01603940 - Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine | Biotech Hunter | Biotech Hunter